Emergency Department Migraine Cocktail: Recommended Medications and Doses
For adults presenting to the ED with acute migraine requiring parenteral therapy, administer prochlorperazine 10 mg IV or metoclopramide 10 mg IV as first-line treatment, combined with ketorolac 30-60 mg IV or dexketoprofen IV, plus dexamethasone 10-24 mg IV to prevent recurrence 1, 2.
First-Line Parenteral Regimen
Primary Agents (Choose One Dopamine Antagonist)
Prochlorperazine: 10 mg IV (Level A - must offer) 1, 2
- Most robust evidence with multiple class I studies
- Effectively relieves headache pain directly, not just nausea 3
Metoclopramide: 10 mg IV (Level B - should offer) 1, 2
- Administer 20-30 minutes before or with other agents 3
- Provides both analgesia and treats gastric motility impairment
Critical Pitfall: Monitor for dystonic reactions with both agents; have diphenhydramine available 3.
Add NSAID Component
Dexketoprofen: IV (Level B - should offer) 1
- Highly likely to be effective based on multiple class I studies
Contraindications: Avoid NSAIDs in aspirin/NSAID-induced asthma, active GI bleeding, cerebrovascular hemorrhage 3.
Recurrence Prevention
- Dexamethasone: 10-24 mg IV (Level B - should offer) 2
- Multiple class I studies support use to prevent headache recurrence
- Essential component of discharge planning
Alternative First-Line Options
For Patients Requiring Migraine-Specific Therapy
For Patients with Prominent Nausea/Vomiting
Use non-oral routes of administration 3:
- Sumatriptan 6 mg SC
- Prochlorperazine 25 mg suppository (maximum 3 doses per 24 hours) 3
- Consider greater occipital nerve block (GONB) - Level A recommendation 1
Second-Line Therapies (When First-Line Fails)
Evidence-Based Options
- Chlorpromazine: IV (Level C - may offer) 1
- Valproate sodium: 500-1000 mg IV 4
- Effective for moderate to severe or treatment-resistant migraine
- Dihydroergotamine (DHE): 0.5-1.0 mg IV/IM 3, 4
- Can repeat every hour to maximum 3 mg IM or 2 mg IV per day
- Maximum 6 mg per week
- Contraindications: Pregnancy, concurrent triptan use, beta blockers 3
Nerve Blocks
- Greater Occipital Nerve Block (GONB): Level A - must offer 1
- Highly likely effective based on multiple class I studies
- Supraorbital Nerve Block (SONB): Level B - should offer 1
What NOT to Use
Avoid as first-line therapy (Level A - must not offer):
Likely ineffective:
Insufficient evidence:
Clinical Algorithm
Assess severity and contraindications
- Check for cardiovascular disease (affects triptan use)
- Assess for NSAID contraindications
- Evaluate pregnancy status
Initiate combination therapy:
- Dopamine antagonist (prochlorperazine 10 mg IV OR metoclopramide 10 mg IV)
- PLUS NSAID (ketorolac 30-60 mg IV)
- PLUS dexamethasone 10-24 mg IV
If inadequate response after 30-60 minutes:
- Add sumatriptan 6 mg SC (if no cardiovascular contraindications)
- OR consider GONB
- OR valproate 500-1000 mg IV
For severe nausea/vomiting:
- Use non-oral routes from onset
- Consider prochlorperazine suppository
Important Caveats
- Medication overuse headache: Warn patients about using acute medications ≥10 days/month for triptans or ≥15 days/month for NSAIDs 6
- Pregnancy: Most agents contraindicated; DHE has oxytocic properties 3
- Recurrence: Occurs in 8-12 hours with triptans; can retreat with second dose 3
- Treatment timing: Administer as early as possible during attack for improved efficacy 3
The 2025 American Headache Society guideline 1 represents the most current evidence and supersedes older recommendations, particularly regarding the strong evidence against opioids and for nerve blocks as first-line options.